

Motley Fool Money
The Motley Fool
Motley Fool Money is a daily podcast for stock investors.Weekday episodes offer a long-term perspective on business news with The Motley Fool's investment analysts. Weekend shows are a mix of investing classes and longer-form interviews.
Episodes
Mentioned books

Aug 10, 2024 • 52min
Nate Silver on Gambling, VCs, and AI
Nate Silver, the founder of FiveThirtyEight and author of "On the Edge," dives into the thrilling parallels between gambling and data analysis. He discusses the psychology behind high-stakes decisions, drawing insights from poker players and venture capitalists. Silver unpacks what keeps investors backing controversial figures like Adam Neumann and why winning bets at DraftKings come with a surcharge. The conversation also touches on the surreal nature of meme-driven market bubbles and how AI is reshaping investment strategies.

Aug 9, 2024 • 40min
Big Trouble or Business as Usual?
Emily Flippen and Jason Moser, seasoned analysts at Motley Fool, dive into the recent Fed-driven market dip and whether it signals something deeper for investors. They tackle antitrust actions against Google and the implications for big tech and shareholders. Bill Mann breaks down the yen carry trade's significant impact on Japan's market and potential investment opportunities. The trio also highlights earning updates from companies like Shopify and Airbnb, comparing their trajectories amidst the shifting economic landscape.

Aug 8, 2024 • 30min
Two Growth Stories
Tim Beyers, an investment analyst known for his tech expertise, and Mary Long, a senior analyst focused on investment strategies, dive into intriguing growth stories. They discuss Toast’s ambitious expansion into grocery and liquor sectors despite market skepticism. Shopify’s stellar financial surge, showcasing a 250% jump in free cash flow, is also explored. The conversation shifts to the importance of crafting a clear investment thesis to navigate volatile markets, emphasizing clarity and simplicity in analysis.

Aug 7, 2024 • 31min
Another Wild Day in the Market
Kirsten Guerra, a market expert, dives into the unexpected drop in Supermicro's stock despite its incredible revenue growth, questioning whether issues are company-specific or part of a broader trend. Meanwhile, Rick Munarriz analyzes Roku's struggle to turn its impressive user engagement into profit, exploring the company's unique position in the streaming world and its future financial prospects. Both guests emphasize the importance of celebrating small victories in investing even amidst ongoing market challenges.

Aug 6, 2024 • 31min
“Since When Has The Fed Known Anything about The Economy?”
Jim Gillies, an investment analyst known for his stock market insights, joins the discussion on navigating current economic uncertainties. They highlight the importance of being a buyer when others are selling, addressing signs of economic strain without inducing panic. The conversation shifts to Celsius Holdings, outlining its impressive revenue growth and the positives from its partnership with PepsiCo. Additionally, listener questions reveal crucial insights on Social Security's future and effective investment strategies for retirement.

Aug 5, 2024 • 28min
The Carry Trade, Nikkei, and Your Portfolio
Jason Moser, a Motley Fool analyst, delves into the impact of the carry trade with the Japanese yen affecting global stock markets, particularly the Nikkei. He shares insights on whether investors should heed Warren Buffett's cash positioning and offers advice on maintaining calm amidst market volatility. Lou Whiteman, a contributor, discusses Nike's struggles leading up to the Olympics, including declining sales and competition. They explore Nike's strategies for regaining consumer loyalty and how aligning innovations with customer preferences may steer the brand back on track.

Aug 4, 2024 • 32min
Where Marvel Goes Next
Dave Gonzales, co-author of 'MCU: The Reign of Marvel Studios,' dives into the future of the Marvel Cinematic Universe. He discusses the implications of Deadpool's $400+ million debut and the evolving storytelling approaches at Disney. Gonzales touches on Ike Perlmutter's ousting, Kevin Feige's expanded creative control, and the shift towards innovative narratives over nostalgia. The conversation also highlights intriguing new directions, including potential returns of iconic characters and fresh storylines that cater to both die-hard fans and casual viewers.

Aug 3, 2024 • 30min
Unit X and the Future of Defense
Christopher Kirchoff, co-founder of the Pentagon's Defense Innovation Unit, is a tech-savvy leader focused on transforming defense. He’s joined by Raj Shah, a venture capitalist who played a pivotal role in this initiative. Together, they discuss how consumer tech can revolutionize military strategies, the challenges of disrupting traditional defense procurement, and the transformative potential of drones and AI in warfare. They also tackle the ethical considerations of AI in military applications and the imperative for innovation in a rapidly changing global landscape.

Aug 2, 2024 • 41min
Big Tech Bets on “Overinvesting”
Ron Gross and Matt Argersinger dive into big tech's massive spending on cloud capabilities and AI growth. They discuss why recent job numbers surge hints at a potential rate cut in 2024. Intel's shocking dividend cut raises historical concerns, while Apple and Meta remain resilient amidst a tough earnings season. With Amazon, Microsoft, and Alphabet investing $45 billion this quarter, they analyze the market's cautious reception of these ambitious moves. Plus, insights into Mercado Libre and Designer Brands make for a compelling stock conversation.

Aug 1, 2024 • 31min
Chips, Glorious Chips!
Asit Sharma, a semiconductor expert, and Karl Thiel, who specializes in medical devices, dive into the latest in tech and healthcare. They discuss AMD's evolving data center business and Meta's AI advancements, particularly its integration into platforms like WhatsApp. The duo also analyzes Dexcom's recent struggles on Wall Street, scrutinizing its revenue challenges and competition from big names like Abbott and Medtronic. This engaging conversation highlights crucial market dynamics for investors.


